Broadfin Capital as of June 30, 2014
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 69 positions in its portfolio as reported in the June 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Flamel Technologies | 7.8 | $79M | 5.3M | 15.00 | |
D Horizon Pharma | 6.8 | $69M | 4.4M | 15.82 | |
AngioDynamics (ANGO) | 4.8 | $49M | 3.0M | 16.33 | |
Emergent BioSolutions (EBS) | 4.6 | $47M | 2.1M | 22.46 | |
BioDelivery Sciences International | 4.0 | $41M | 3.4M | 12.07 | |
AMAG Pharmaceuticals | 4.0 | $41M | 2.0M | 20.72 | |
Heron Therapeutics (HRTX) | 3.4 | $35M | 2.8M | 12.32 | |
DepoMed | 3.4 | $34M | 2.5M | 13.90 | |
Progenics Pharmaceuticals | 2.8 | $29M | 6.6M | 4.31 | |
Tetraphase Pharmaceuticals | 2.8 | $29M | 2.1M | 13.49 | |
Aegerion Pharmaceuticals | 2.6 | $26M | 810k | 32.09 | |
Anacor Pharmaceuticals In | 2.5 | $26M | 1.4M | 17.73 | |
Pernix Therapeutics Holdings | 2.5 | $25M | 3.5M | 7.18 | |
Retrophin | 2.5 | $25M | 1.7M | 14.85 | |
Derma Sciences | 2.1 | $21M | 1.8M | 11.56 | |
Universal American | 2.1 | $21M | 2.5M | 8.33 | |
Rigel Pharmaceuticals (RIGL) | 2.0 | $20M | 5.6M | 3.63 | |
Novadaq Technologies | 2.0 | $20M | 1.2M | 16.48 | |
Natus Medical | 1.9 | $19M | 765k | 25.14 | |
Impax Laboratories | 1.8 | $18M | 609k | 29.99 | |
AtriCure (ATRC) | 1.8 | $18M | 985k | 18.38 | |
Discovery Laboratories | 1.4 | $14M | 8.1M | 1.78 | |
Aratana Therapeutics | 1.3 | $13M | 817k | 15.61 | |
Dynavax Technologies Corporation | 1.2 | $12M | 7.7M | 1.60 | |
Rite Aid Corporation | 1.1 | $12M | 1.6M | 7.17 | |
Liberator Medical Hld | 1.1 | $12M | 3.1M | 3.75 | |
Eleven Biotherapeutics | 1.1 | $11M | 858k | 13.18 | |
IGI Laboratories | 1.1 | $11M | 2.1M | 5.31 | |
Corium Intl | 1.1 | $11M | 1.4M | 7.77 | |
Syneron Medical Ltd ord | 1.0 | $10M | 1.0M | 10.32 | |
Zogenix | 1.0 | $10M | 5.1M | 2.01 | |
Idera Pharmaceuticals | 1.0 | $10M | 3.5M | 2.90 | |
Cempra | 1.0 | $10M | 955k | 10.73 | |
Brookdale Senior Living (BKD) | 1.0 | $10M | 303k | 33.34 | |
Cardica | 1.0 | $10M | 8.9M | 1.14 | |
BioScrip | 0.9 | $9.6M | 1.1M | 8.34 | |
Xencor (XNCR) | 0.9 | $9.0M | 775k | 11.62 | |
Sagent Pharmaceuticals | 0.8 | $8.5M | 330k | 25.86 | |
Qlt | 0.8 | $8.2M | 1.3M | 6.18 | |
Antares Pharma | 0.8 | $8.1M | 3.1M | 2.67 | |
DURECT Corporation | 0.8 | $8.0M | 4.4M | 1.82 | |
Oxygenbiotherapeutics Inccom Par | 0.8 | $8.0M | 2.0M | 4.08 | |
Tonix Pharmaceuticls | 0.7 | $6.7M | 468k | 14.35 | |
Chemocentryx | 0.6 | $6.1M | 1.1M | 5.85 | |
Auxilium Pharmaceuticals | 0.6 | $6.0M | 300k | 20.06 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.6 | $6.1M | 2.4M | 2.53 | |
Ignyta | 0.6 | $5.8M | 225k | 25.92 | |
CareFusion Corporation | 0.6 | $5.5M | 125k | 44.35 | |
Pozen | 0.6 | $5.5M | 660k | 8.33 | |
Recro Pharma (SCTL) | 0.5 | $5.4M | 672k | 8.01 | |
Aquinox Pharmaceuticals | 0.5 | $4.8M | 511k | 9.43 | |
Redhill Biopharma Ltd cmn | 0.5 | $4.6M | 263k | 17.49 | |
Dipexium Pharmaceuticals | 0.5 | $4.6M | 475k | 9.70 | |
Agenus (AGEN) | 0.4 | $3.8M | 1.2M | 3.22 | |
Mirati Therapeutics | 0.4 | $3.7M | 185k | 20.00 | |
La Jolla Pharmaceuticl Com Par | 0.3 | $3.6M | 388k | 9.18 | |
Flexion Therapeutics | 0.3 | $3.5M | 263k | 13.48 | |
Rxi Pharmaceuticals | 0.3 | $3.4M | 1.1M | 3.02 | |
Trevena | 0.3 | $3.4M | 600k | 5.65 | |
Biota Pharmaceuticals | 0.3 | $3.2M | 1.1M | 2.85 | |
Biodel | 0.3 | $2.9M | 1.3M | 2.16 | |
Celsus Therapeutics Plc sponsored adr ne | 0.3 | $2.9M | 471k | 6.20 | |
CAS Medical Systems | 0.3 | $2.9M | 1.4M | 2.01 | |
Anthera Pharmaceutcls | 0.3 | $2.6M | 766k | 3.39 | |
Lipocine | 0.2 | $1.6M | 265k | 6.10 | |
Digirad Corporation | 0.1 | $1.2M | 333k | 3.56 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $443k | 1.5k | 295.33 | |
Teva Pharmaceutical Industries (TEVA) | 0.0 | $210k | 4.0k | 52.50 | |
Haemonetics Corporation (HAE) | 0.0 | $127k | 3.6k | 35.28 |